Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and MicroRNA Biomarkers in Endometrial Hyperplasia Without Atypia
NCT05292573Phase 3Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2018
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in Endometrial Hyperplasia Without Atypia (EH), sponsored by Chang Gung Memorial Hospital. Started Aug 2018; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Endometrial Hyperplasia Without Atypia (EH)
Beyond the preview
Go deeper on NCT05292573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05292573.